Pirogov Russian National Research Medical University is a medical higher education institution in Moscow, Russia founded in 1906. It is fully accredited and recognized by Russia's Ministry of Education and Science and is currently under the authority of the Ministry of Health and Social Development.

During the past decade, Pirogov Russian National Research Medical University conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 15 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 14 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pirogov Russian National Research Medical University" #1 sponsor was "Materia Medica Holding" with 13 trials, followed by "Pirogov Russian National Research Medical University" with 6 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pirogov Russian National Research Medical University" #1 collaborator was "Nippon Shinyaku Co., Ltd." with 2 trials as a collaborator, "City Clinical Hospital No.52 of Moscow Healthcare Department" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "ResearchPoint Global" with 1 trials as a collaborator and "State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pirogov Russian National Research Medical University" are "Acute Respiratory Viral Infections" (2 trials), "COVID-19" (2 trials), "Dravet Syndrome (DS)" (2 trials), "Duchenne Muscular Dystrophy" (2 trials) and "Lennox Gastaut Syndrome (LGS)" (2 trials). Many other conditions were trialed in "Pirogov Russian National Research Medical University" in a lesser frequency.

Most popular intervention types in "Pirogov Russian National Research Medical University" are "Drug" (38 trials), "Other" (4 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Ergoferon" (3 trials), "Soticlestat" (3 trials), "Tenoten for children" (3 trials) and "Tirzepatide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pirogov Russian National Research Medical University" are 39 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 16 active trials in "Pirogov Russian National Research Medical University". 1 are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 25 completed trials in Pirogov Russian National Research Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pirogov Russian National Research Medical University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 1 trials that are defined as “Not Applicable".

Pirogov Russian National Research Medical University has several departments that took part in Clinical trials: "Russian Children Clinical Hospital" - 2 trials